Social Burden and Goals of Therapy for Patients with Bronchiectasis
A medical professional addresses the social aspects of bronchiectasis, emphasizing patients' embarrassment due to productive coughing in public spaces like grocery stores and churches, as well as the psychological challenges of planning travel and vacations due to the unpredictability of exacerbations, which can lead to social isolation.
Opinion
Video
Social Burden and Goals of Therapy for Patients with Bronchiectasis
A medical professional addresses the social aspects of bronchiectasis, emphasizing patients' embarrassment due to productive coughing in public spaces like grocery stores and churches, as well as the psychological challenges of planning travel and vacations due to the unpredictability of exacerbations, which can lead to social isolation.
EP: 1.Overview of Bronchiectasis
EP: 2.Prognosis For Patients Diagnosed With Bronchiectasis
EP: 3.Indicators Leading to Bronchiectasis Testing and Diagnosis
EP: 4.Complications Associated With Bronchiectasis
EP: 5.Current Treatment Options For Bronchiectasis
EP: 6.Respiratory and Physical Therapists Contributing to Comprehensive Bronchiectasis Care
EP: 7.Key Areas of Research and Emerging Therapies In Bronchiectasis Treatment
EP: 8.Diagnosing and Understanding the Pathogenesis of Bronchiectasis
EP: 9.Improving Long-Term Outlook: CT Scans and Underdiagnosis of Bronchiectasis
EP: 10.Bronchiectasis Exacerbation Management
EP: 11.Social Burden and Goals of Therapy for Patients with Bronchiectasis
EP: 12.Patient Specific Factors: Guiding Treatment in Bronchiectasis
EP: 13.Individualized Therapy for Specific Infections Associated with Bronchiectasis
EP: 14.Other Challenges With Bronchiectasis and Key Takeaways
EP: 15.Identifying Bronchiectasis: Key Clinical Presentations to Consider
EP: 16.Differentiating Bronchiectasis from COPD and Understanding Exacerbations
EP: 17.Long-Term Impact of Bronchiectasis Exacerbations: Disease Progression, Patient Outcomes, and Economic Burden
EP: 18.Managing Bronchiectasis: Treatment Goals, Outcome Measures, and Clinical Decision Resources
EP: 19.Addressing Knowledge Gaps and Treatment Strategies in Bronchiectasis
EP: 20.Challenges and Future Directions in Bronchiectasis Management
CMS, HHS Finalize Mandatory Model to Boost Kidney Transplant Access, Equity
Breaking the Cycle: The Importance of Early Intervention in Hidradenitis Suppurativa
Baseline Response Rates Inform Immunotherapy Sequencing in NSCLC
Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value
sGFAP May Predict Progression Independent of Relapse in BCDT-Treated MS
Authors Identify Monoclonal Antibody to Selectively Target CALR Mutations in MPNs
CMS, HHS Finalize Mandatory Model to Boost Kidney Transplant Access, Equity
Breaking the Cycle: The Importance of Early Intervention in Hidradenitis Suppurativa
Baseline Response Rates Inform Immunotherapy Sequencing in NSCLC
Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value
sGFAP May Predict Progression Independent of Relapse in BCDT-Treated MS
Authors Identify Monoclonal Antibody to Selectively Target CALR Mutations in MPNs